ROCK CREEK PHARMACEUTICALS, INC.
ROCK CREEK PHARMACEUTICALS, INC.
SARASOTA, FL
Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 0.01 |
| Currency | USD |
Key Financial Metrics
-
Revenue
-11.15M
Net Income
-
EPS (Diluted)
-
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
-8.67M
Returns & Efficiency
Return on Assets (ROA)
-94.7%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
11.78M
Total Debt
2.74M
Debt to Equity
-
Current Ratio
0.01
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | SARASOTA, FL |
| Fiscal Year | 2015 |
Peers
TRULIEVE CANNABIS CORP.
TCNNF
2.31B
P/E: --
CRONOS GROUP INC.
CRON
1.44B
P/E: --
TILRAY, INC.
TLRY
682.34M
P/E: --
TILRAY BRANDS, INC.
TLRY
682.34M
P/E: --
Tilray Brands, Inc.
TLRY
682.34M
P/E: --
654.42M
P/E: --
CHROMADEX CORP.
NAGE
383.49M
P/E: 21.0
383.49M
P/E: 21.0
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-
Net Margin-
ROE-
ROA-94.7%
Leverage & Liquidity
Debt to Equity-
Current Ratio0.01
Total Debt$2.74M
Total Assets$11.78M
Stockholders' Equity$-12.99M
Income Statement (FY 2015)
Revenue-
Gross Profit-
Operating Income$-8.86M
Net Income$-11.15M
EPS (Diluted)-
Cash Flow (FY 2015)
Free Cash Flow-
Cash & Equivalents$185.00K
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 2040 WHITFIELD AVENUE SUITE 300 SARASOTA, FL 34243 |
| Phone | 804-527-1970 |
| Incorporated | DE, US |
| EIN | 521402131 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 153.61M |
| Stockholders' Equity | $-12.99M |
| Cash & Equivalents | $185.00K |
Recent Filings
View All
REVOKED
REVOKED Filing
SEC regulatory filing
Filed: 2023-02-14
8-K
Current Report
2016-09-28 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-09-28
8-K
Current Report
2016-08-24 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-08-29
8-K
Current Report
2016-08-12 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-08-17
10-Q
Quarterly Report
2016-06-30 • Quarterly financial report with unaudited statements
Filed: 2016-08-10
View
DEF 14A
Definitive Proxy Statement
2016-08-12 • Official proxy statement for shareholder voting
Filed: 2016-07-22
PRE 14A
Preliminary Proxy Statement
2016-08-12 • Preliminary proxy statement for SEC review
Filed: 2016-07-11
8-K
Current Report
2016-07-01 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-07-08
8-K
Current Report
2016-07-07 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-07-08
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2016-07-08
8-K
Current Report
2016-05-16 • Report of material events (acquisitions, earnings, executive changes)
Filed: 2016-05-16
S-8
Employee Plan Registration
Registration for employee benefit plan securities
Filed: 2016-05-16
10-Q
Quarterly Report
2016-03-31 • Quarterly financial report with unaudited statements
Filed: 2016-05-16
View
424B3
Prospectus (Rule 424b3)
Prospectus filed under Rule 424(b)(3)
Filed: 2016-04-29
10-K/A
Amended Annual Report
2015-12-31 • Amendment to previously filed annual report
Filed: 2016-04-29
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ROCK CREEK PHARMACEUTICALS, INC. |
| Ticker | None |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | SARASOTA, FL |
| Fiscal Year | 2015 |
Financial Summary
| Market Cap | - |
| Revenue | - |
| Net Income | -11.15M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | - |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...